Laurus Labs Ltd. (LAURUSLABS) 52 Week High Streak: Second Straight Session, 1.03% Move
- September 15, 2026
- Posted by: Harsh Piplani
- Category: News
Laurus Labs Ltd. (LAURUSLABS) 52 Week High Streak has now extended to its second straight session, with the stock touching a fresh one-year peak of Rs 1,981. Across the streak, it has moved up 1.03%. According to latest Univest data, this pattern confirms the repeated-high setup, while the figures do not establish a company-specific catalyst for the continued move.
The stock last traded at Rs 1,955.9 after a previous close of Rs 1,970.35, with the day’s trade range spanning Rs 1,946.7 to Rs 1,981. Turnover stood at Rs 1.03 crore and market capitalisation at Rs 1,06,460.42 crore. For readers, the repeated-high pattern is more informative than a single breakout because it shows that the one-year peak has been revisited on consecutive sessions rather than appearing once and fading immediately.
Laurus Labs 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,955.9 |
| Previous Close | Rs 1,970.35 |
| Today's Move | Rs -14.45 (-0.73%) |
| Open | Rs 1,973 |
| High | Rs 1,981 |
| Low | Rs 1,946.7 |
| Turnover | Rs 1.03 crore |
| Market Capitalisation | Rs 1,06,460.42 crore |
Laurus Labs Ltd. (LAURUSLABS) traded at Rs 1,955.9 versus the previous close of Rs 1,970.35, a fall of 0.73%. The stock opened at Rs 1,973, reached a high of Rs 1,981 and touched a low of Rs 1,946.7.
Laurus Labs share price today moved below the previous close even after touching a fresh 52-week high, which keeps the session interesting from a market-news perspective. The stock traded at Rs 1,955.9, down Rs 14.45 or 0.73% from Rs 1,970.35. It opened at Rs 1,973, moved to a high of Rs 1,981 and a low of Rs 1,946.7, and therefore traded within a relatively narrow band around the one-year peak. That range matters because the latest high matched the fresh 52-week high while the last traded price remained near the upper half of the day’s range.
Turnover was Rs 1.03 crore, and market capitalisation stood at Rs 1,06,460.42 crore. The stock’s latest one-year peak follows the first breakout seen on the earlier session in the streak, but the chart narrative alone cannot explain why the move has continued. For a reader tracking Laurus Labs share price today, the key takeaway is the repeated-high structure itself, not just the day’s percentage change.
Laurus Labs Ltd. 52 Week High Streak: Consecutive High Analysis
Direct answer: Laurus Labs has now set a fresh 52-week high for its second straight session, and the cumulative move across that streak is 1.03%. The latest peak at Rs 1,981 sits above the prior one-year high from the earlier breakout session, showing that the stock has not just tested the level once but has revisited it on consecutive trading days.
That pattern matters because a repeated 52-week high is different from a single-day headline. The first session established the breakout, while the next session showed that the stock could return to the same one-year high zone rather than retreating sharply away from it. The latest reading gives investors a clearer view of Laurus Labs 52 Week High Streak behaviour, especially for those scanning Stocks Hitting 52 Week Highs or Stocks At One Year High Today.
The confirmed numbers support the streak label, the latest peak and the cumulative gain. They do not, however, identify any company-specific event behind the move. That distinction is important for anyone following Laurus Labs New One Year High headlines or looking for a Back to Back 52 Week Highs pattern without assuming a fresh business catalyst.
What the Repeated 52-Week Highs Show
Direct answer: The repeated highs show that Laurus Labs has remained near its fresh one-year peak across more than one session, which makes the pattern more durable than a one-off breakout. The latest market reading confirms the streak, but it also shows that the stock is still trading close to its peak rather than materially above it.
For readers searching Why Is Laurus Labs Still Hitting 52 Week Highs, the answer has to stay factual: the price pattern is confirmed, but the data here does not establish a company-specific reason. That is why the streak should be read as a market observation first and a story second. It tells investors that Laurus Labs share price update is still being watched closely, especially when the stock appears in 52 Week High Stocks screens and Stock News feeds.
The current setup is also useful from a comparison standpoint. A second straight one-year high can attract attention because it shows continuity, yet the stock’s last traded price below the high means the market is still testing acceptance around the level. That makes the move relevant for traders, long-term holders and anyone checking whether the company’s current stock performance is being sustained session after session.
Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,06,460.42 crore |
| P/E Ratio | 97.37x |
| P/B Ratio | 18.88x |
| ROE | 18.31% |
| ROCE | 18.2% |
| EPS | Rs 20.24 |
| Book Value Per Share | Rs 104.37 |
| Dividend Yield | 0.1% |
Laurus Labs Ltd. (LAURUSLABS) fundamental metrics show P/E 97.37x, P/B 18.88x, ROE 18.31%, ROCE 18.2%. These figures provide context only and are not a buy or sell signal.
Laurus Labs Ltd. has a market capitalisation of Rs 106460.42 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 97.37x, P/B at 18.88x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.31% and ROCE of 18.2%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.24, book value per share of Rs 104.37, dividend yield of 0.1%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.41x, median ROE of 11.61%, median ROCE of 13.18%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 97.37x |
| Benchmark Median P/E | 32.41x |
| Benchmark Average P/E | 48.86x |
| Benchmark P/E Range | 3.34x to 693.7x |
| Company P/B Ratio | 18.88x |
| Benchmark Median P/B | 3.04x |
| Company ROE | 18.31% |
| Benchmark Median ROE | 11.61% |
| Company ROCE | 18.2% |
| Benchmark Median ROCE | 13.18% |
| Company Market Capitalisation | Rs 1,06,460.42 crore |
| Benchmark Median Market Cap | Rs 692.38 crore |
Laurus Labs Ltd. (LAURUSLABS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 97.37x, which is above the benchmark median of 32.41x, a difference of +200.43%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Laurus Labs Ltd. (LAURUSLABS) has a ROE of 18.31%, which is above the benchmark median of 11.61%, a difference of +57.71%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 18.2%, which is above the benchmark median of 13.18%, a difference of +38.09%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Cipla Ltd. | CIPLA | 1,10,272.68 | 32.72 | 3.14 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,670.55 | 24.74 | 4.14 | 19.69 | 21.39 |
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 96,906.38 | 30.07 | 2.54 | 11.69 | 13.75 |
| Aurobindo Pharma Ltd. | AUROPHARMA | 96,401.69 | 25.97 | 2.48 | 9.93 | 12.76 |
| Lupin Ltd. | LUPIN | 95,842.92 | 17.34 | 4.03 | 27.11 | 28.86 |
Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 97.37x compared with the displayed peer median of 25.97x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.31% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 18.2% versus the displayed peer median of 16%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 1,06,460.42 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Laurus Labs
- Laurus Labs has now set a fresh 52-week high for its second straight session.
- The cumulative move across the streak is 1.03%, which gives the repeated-high pattern a measurable shape.
- The latest peak of Rs 1,981 is the key reference point for Laurus Labs 52 Week High Streak tracking.
- The stock’s P/E of 97.37 and P/B of 18.88 make Laurus Labs Stock Analysis a valuation-focused watchlist item.
- ROE of 18.31% and ROCE of 18.2% keep Laurus Labs Fundamental Analysis relevant alongside the price action.
About Laurus Labs
Direct answer: Laurus Labs Ltd. is a listed Healthcare company in the Pharmaceuticals & Drugs industry. It has a market capitalisation of Rs 1,06,460.42 crore, and its latest stock market update places it among the more closely watched names in the sector because of both valuation and performance tracking.
The company’s current financial ratios include EPS of Rs 20.24, book value of Rs 104.37 and a dividend yield of 0.1%. For readers following Laurus Labs Company News or Laurus Labs Stock Performance, these figures help set the backdrop for the latest one-year high streak. The stock remains a major name in the healthcare basket and continues to draw attention whenever it appears in 52 Week High Stocks or related market screens.
Track Laurus Labs on Univest
Direct answer: Track Laurus Labs share price, stock news and market updates on Univest for the latest move around the fresh 52-week high streak. The stock page keeps the key market metrics in one place for quick reference during live market hours.
For investors monitoring Laurus Labs New One Year High behaviour, the stock page can help follow the next price update, company news and sector context without losing sight of the repeated-high pattern.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What does Laurus Labs 52 Week High Streak mean?
Ans. It means Laurus Labs has set a fresh 52-week high on consecutive trading sessions. In this case, the streak has reached the second straight session, which is more informative than a single-day breakout because it shows repetition around the same peak.
How many sessions has Laurus Labs set a fresh 52-week high?
Ans. According to latest Univest data, Laurus Labs has now set a fresh 52-week high for two consecutive sessions. The streak label used for this event is second straight session.
What is the cumulative move in Laurus Labs 52 Week High Streak?
Ans. The cumulative move across the streak is 1.03%. That figure is the key streak metric for this article because it captures the full multi-session move rather than only the latest day’s change.
What is the current share price of Laurus Labs Ltd. (LAURUSLABS)?
Ans. Laurus Labs Ltd. (LAURUSLABS) last traded at Rs 1,955.9. That is against a previous close of Rs 1,970.35, a move of 0.73% so far today.
Track Laurus Labs Ltd. (LAURUSLABS) Share Price on Univest
Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
